Abstract
Gentiopicroside (GPS), a single compound isolated from Gentiana lutea L. and the crucial representative of secoiridoid constituent, has been permitted for centuries in traditional Chinese medicine. GPS and its metabolites have been increasingly used in the search for clinical management with therapeutic properties and fewer side effects. The objective of this review was to provide a comprehensive overview of the involvement of molecular pathways in the therapeutic effects of GPS on human diseases and chronic conditions. This study presents a meticulously conducted comprehensive search of the PubMed and Google Scholar databases (from 1983 to 2023), aimed at identifying articles relating to regulatory mechanisms of GPS on human diseases and the pharmacokinetics of GPS. The inclusion criteria were meticulously and precisely defined to encompass original research papers that explicitly focused on elucidating the regulatory mechanisms of GPS in various human diseases through in vitro and animal studies. Notably, these studies were mandated to integrate specific genetic markers or pathways as essential components of their research inquiries. The evaluated pharmacokinetic parameters included maximum plasma concentration (Cmax), time to reach maximum plasma concentration (Tmax), area under the curve (AUC), clearance, and plasma half-life (t1/2). Subsequently, through a rigorous screening process of titles and abstracts, studies conducted in vitro or on animals, as well as those reporting pharmacokinetic data related to drugs other than GPS or language barriers, were systematically excluded. Drawing from the data and studies pertaining to this review, we conducted a thorough and informative analysis of the pharmacological characteristics and biological functions of GPS. These encompassed a wide range of effects, including hepatoprotective, anti-inflammatory, antifibrotic, antioxidant, analgesic, antitumor, and immunomodulatory properties. The analysis provided a comprehensive and insightful understanding of GPS’s pharmacological profile and its diverse activities. Enhancing theoretical and experimental methodologies could prove advantageous in expanding the clinical applications of GPS. This could involve optimizing the bioavailability and pharmacokinetics of GPS, uncovering additional biomarkers and potential biotransformation pathways, and investigating its combined effects with standard-of-care medications.
Similar content being viewed by others
Availability of data and materials
This review is a concise presentation of a proposed hypothesis, and therefore, no scientific or experimental data was presented.
Abbreviations
- AA:
-
Adjuvant-induced arthritis
- ALD:
-
Alcoholic liver damage
- ALDH1L1:
-
Aldehyde dehydrogenase family 1-member L1
- ANCC:
-
Anterior cingulate cortex
- ANIT:
-
Alpha-naphthylisothiocyanate
- ARA:
-
Arachidonic acid
- ASC:
-
Apoptosis-associated speck-like protein containing
- AT1R:
-
Angiotensin II type 1 receptor
- ATP:
-
Adenosine triphosphate
- AUC:
-
Area under the curve
- BALF:
-
Bronchoalveolar lavage fluid
- Bas:
-
Bile acids
- BDNF:
-
Brain-derived neurotrophic factor
- BMSCs:
-
Bone mesenchymal stem cells
- BUN:
-
Blood urea nitrogen
- CAT:
-
Catalase
- CC:
-
Cervical cancer
- CF:
-
Cardiac fibrosis
- CFs:
-
Cardiac fibroblasts
- CIA:
-
Collagen-induced arthritis
- CK2:
-
Creatine Kinase 2
- CL:
-
Clearance
- C max :
-
Maximum plasma concentration
- CNS:
-
Central nervous system
- CoA:
-
Coenzyme A
- COX-2:
-
Cyclooxygenase-2
- Cr:
-
Creatinine
- CRP:
-
C-reactive protein
- CTGF:
-
Connective tissue growth factor
- Cyp7a1:
-
Cholesterol 7-alpha hydroxy-lase
- DA:
-
Dopamine
- DDB2:
-
DNA-binding protein 2
- Dex:
-
Dexamethasone
- DN:
-
Diabetic nephropathy
- DPN:
-
Diabetic peripheral neuropathy
- EF:
-
Ejection fraction
- EMMPRIN:
-
MMP inducer
- EMT:
-
Epithelial-mesenchymal transition
- EPSCs:
-
Excitatory postsynaptic currents
- ERK:
-
Extracellular signal-regulated kinase
- FBG:
-
Fasting blood glucose
- FFA:
-
Free fatty acid
- FN:
-
Fibronectin
- FS:
-
Fraction shortening
- GCLM:
-
Glutamate-cysteine ligase regulatory subunit
- GFP:
-
Green fluorescent protein
- GPS:
-
Gentiopicroside
- GSH:
-
Glutathione
- GSH-Px:
-
Glutathione peroxidase
- GSP:
-
Glycated serum protein
- HbA1c:
-
Hemoglobin A1c
- HFLS:
-
Human fibroblast-like synoviocytes
- HG:
-
High glucose
- HO-1:
-
Heme oxygenase-1
- Hyp:
-
Hydroxyproline
- IFN:
-
Interferon
- IgE:
-
Immunoglobulin E
- IL:
-
Interleukin
- iNOS:
-
Inducible nitric oxide synthase
- JNK:
-
Jun N-terminal kinase
- LDL-C:
-
Low-density lipoprotein cholesterol
- LEF:
-
Leflunomide
- LVIDd:
-
Left ventricular diastolic dimension
- LVIDs:
-
Left ventricular internal diameter systole
- MAPK:
-
Mitogen-activated protein kinase
- MAPKs:
-
Mitogen-activated protein kinases
- MDA:
-
Malondialdehyde
- MIC:
-
Minimum inhibitory concentration
- MMP:
-
Matrix metallopeptidase
- MPO:
-
Myeloperoxidase
- Mrp4:
-
Multidrug resistance protein 4
- MTX:
-
Methotrexate
- NAFLD:
-
Nonalcoholic fatty liver disease
- NCV:
-
Nerve conduction velocity
- NE:
-
Norepinephrine
- NF-κB:
-
Nuclear factor kappa B
- NLRP3:
-
NOD-like receptor protein 3
- NMDAR:
-
N-Methyl-Daspartate Receptors
- NO:
-
Nitric oxide
- NQO1:
-
NAD(P)H:quinone oxidoreductase 1
- Nrf2:
-
Nuclear factor erythroid 2-related factor 2
- OCN:
-
Osteocalcin
- OPN:
-
Osteopontin
- OSX:
-
Osterix
- OVA:
-
Ovalbumin
- OVX:
-
Ovariectomized
- PA:
-
Palmitic acid
- PAQR3:
-
AdipoQ receptor 3
- PCA:
-
Principal component analysis
- PCNA:
-
Proliferating cell nuclear antigen
- PCO:
-
Protein carbonyl
- PE:
-
Phenylephrine
- PGE2:
-
Prostaglandin E2
- PF:
-
Pulmonary fibrosis
- PPARα:
-
Peroxisome proliferator-activated receptor α
- RA:
-
Rheumatoid arthritis
- RANKL:
-
Receptor activator of nuclear factor kappa B ligand
- RAS:
-
Renin-angiotensin system
- RASMCs:
-
Rat aortic smooth muscle cells
- Runx2:
-
Runt-related transcription factor 2
- SIRT1:
-
Silent information regulator 1
- SNCV:
-
Sensory nerve conduction velocity
- SOD:
-
Superoxide dismutase
- SRB:
-
Sulpharhodamine B
- Src:
-
Serum creatinine
- SREBP-1c:
-
Sterol regulatory element-binding protein-1c
- t1/2 :
-
Half-life
- T-αMCA:
-
Tauro-α-mouse cholic acid
- T-ωMCA:
-
Tauro-ω mouse cholic acid
- TBA:
-
Total bile acids
- TBIL:
-
Total bilirubin
- TC:
-
Total cholesterol
- TCA:
-
Taurocholic acid
- TAG:
-
Triacylglycerol
- Th2:
-
T helper type 2
- TIF:
-
Tubulointerstitial fibrosis
- TIMP-1:
-
Tissue inhibitor of metal protease1
- T max :
-
Time to reach maximum plasma concentration
- TNF:
-
Tumor necrosis factor
- TUDCA:
-
Tauroursodeoxycholic acid
- Ty:
-
Tyloxapol
- UDCA:
-
Ursodeoxycholic acid
- Up:
-
24-H urine protein
- VEGF:
-
Vascular endothelial growth factor
- VSM:
-
Vascular smooth muscle
- 5-HT:
-
5-Hydroxytryptamine
- α-SMA:
-
α-Smooth muscle actin
- β-MCA:
-
β-Mouse cholic acid
- ω-MCA:
-
ω-Mouse cholic acid
- ΔΨm:
-
Mitochondrial membrane potential
References
Aberham A, Schwaiger S, Stuppner H, Ganzera M (2007) Quantitative analysis of iridoids, secoiridoids, xanthones and xanthone glycosides in Gentiana lutea L. roots by RP-HPLC and LC-MS. Journal of pharmaceutical and biomedical analysis 45(3):437–442
Annesley SJ, Fisher PR (2019) Mitochondria in Health and Disease. Cells 8(7):680
Brahmachari G, Mondal S, Gangopadhyay A, Gorai D, Mukhopadhyay B, Saha S, Brahmachari AK (2004) Swertia (Gentianaceae): chemical and pharmacological aspects. Chem Biodivers 1(11):1627–1651
Chang Y, Tian Y, Zhou D, Yang L, Liu TM, Liu ZG, Wang SW (2021) Gentiopicroside ameliorates ethanol-induced gastritis via regulating MMP-10 and pERK1/2 signaling. Int Immunopharmacol 90:107213
Chang-Liao WL, Chien CF, Lin LC, Tsai TH (2012) Isolation of gentiopicroside from Gentianae Radix and its pharmacokinetics on liver ischemia/reperfusion rats. J Ethnopharmacol 141(2):668–673
Chen L, Liu JC, Zhang XN, Guo YY, Xu ZH, Cao W, Sun XL, Sun WJ, Zhao MG (2008) Down-regulation of NR2B receptors partially contributes to analgesic effects of Gentiopicroside in persistent inflammatory pain. Neuropharmacology 54(8):1175–1181
Chen C, Wang YY, Wang YX, Cheng MQ, Yin JB, Zhang X, Hong ZP (2018a) Gentiopicroside ameliorates bleomycin-induced pulmonary fibrosis in mice via inhibiting inflammatory and fibrotic process. Biochem Biophys Res Commun 495(4):2396–2403
Chen F, Xie L, Kang R, Deng R, Xi Z, Sun D, Zhu J, Wang L (2018) Gentiopicroside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and JNK signaling pathways. Biomed Pharmacother = Biomedecine Pharmacotherapie 100:142–146
Chi X, Zhang F, Gao Q, Xing R, Chen S (2021) A review on the ethnomedicinal usage, phytochemistry, and pharmacological properties of Gentianeae (Gentianaceae) in Tibetan medicine. Plants (basel, Switzerland) 10(11):2383
Chiba K, Yamazaki M, Kikuchi M, Kakuda R, Kikuchi M (2011) New physiological function of secoiridoids: neuritogenic activity in PC12h cells. J Nat Med 65(1):186–190
China Pharmacopoeia committee (2010) The People’s Republic of China Pharmacopoeia (a). Chinese medical science and technology press, Beijing, p 253
Choi RY, Nam SJ, Lee HI, Lee J, Leutou AS, Ri Ham J, Lee MK (2019) Gentiopicroside isolated from Gentiana scabra Bge. inhibits adipogenesis in 3T3-L1 cells and reduces body weight in diet-induced obese mice. Bioorg Med Chem Lett 29(14):1699–1704
Dai YH, Wang M, Zhu YN, Wang LL, Ju JM, Zhang ZH (2016) [Effect of D-cellobiose on oral bioavailability of gentiopicroside]. Zhongguo Zhong Yao Za Zhi 41(10):1855–1859. Chinese. https://doi.org/10.4268/cjcmm20161015
Darby IA, Hewitson TD (2007) Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257:143–179
Deng Y, Wang L, Yang Y, Sun W, Xie R, Liu X, Wang Q (2013) In vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6. Drug Metab Pharmacokinet 28(4):339–344
Deng YT, Wang XS, Zhao MG, Huang XX, Xu XL (2018) Gentiopicroside protects neurons from astrocyte-mediated inflammatory injuries by inhibition of nuclear factor-κB and mitogen-activated protein kinase signaling pathways. NeuroReport 29(13):1114–1120
Dinarello CA (2010) Anti-inflammatory agents: present and future. Cell 140(6):935–950
Ekrem S, Mustafa A, Erdem Y, Shigeru I (2005) Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques. Life Sci 76(11):1223–1238
El-Sedawy AI, Hattori M, Kobashi K, Namba T (1989) Metabolism of gentiopicroside (gentiopicrin) by human intestinal bacteria. Chem Pharm Bull 37(9):2435–2437
Han H, Xu L, Xiong K, Zhang T, Wang Z (2018) Exploration of hepatoprotective effect of Gentiopicroside on alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats by comprehensive proteomic and metabolomic signatures. Cell Physiol Biochem 49(4):1304–1319
He M, Hu C, Chen M, Gao Q, Li L, Tian W (2022) Effects of Gentiopicroside on activation of NLRP3 inflammasome in acute gouty arthritis mice induced by MSU. J Nat Med 76(1):178–187
Hu Z, Wang H, Fu Y, Ma K, Ma X, Wang J (2021) Gentiopicroside inhibits cell growth and migration on cervical cancer via the reciprocal MAPK/Akt signaling pathways. Nutr Cancer 73(8):1459–1470
Huang Y, Lin J, Yi W, Liu Q, Cao L, Yan Y, Fu A, Huang T, Lyu Y, Huang Q, Wang J (2020) Research on the potential mechanism of Gentiopicroside against gastric cancer based on network pharmacology. Drug Des Dev Ther 14:5109–5118
Jia N, Ma H, Zhang T, Wang L, Cui J, Zha Y, Ding Y, Wang J (2022) Gentiopicroside attenuates collagen-induced arthritis in mice via modulating the CD147/p38/NF-κB pathway. Int Immunopharmacol 108:108854
Jiang RW, Wong KL, Chan YM, Xu HX, But PP, Shaw PC (2005) Isolation of iridoid and secoiridoid glycosides and comparative study on Radix gentianae and related adulterants by HPLC analysis. Phytochemistry 66(22):2674–2680
Jiang H, Zhong J, Li W, Dong J, Xian CJ, Shen YK, Yao L, Wu Q, Wang L (2021a) Gentiopicroside promotes the osteogenesis of bone mesenchymal stem cells by modulation of β-catenin-BMP2 signalling pathway. J Cell Mol Med 25(23):10825–10836
Jiang M, Cui BW, Wu YL, Nan JX, Lian LH (2021b) Genus Gentiana: a review on phytochemistry, pharmacology and molecular mechanism. J Ethnopharmacol 264:113391
Jin M, Feng H, Wang Y, Yan S, Shen B, Li Z, Qin H, Wang Q, Li J, Liu G (2020) Gentiopicroside ameliorates oxidative stress and lipid accumulation through nuclear factor erythroid 2-related factor 2 activation. Oxid Med Cell Longev 2020:2940746
Kesavan R, Potunuru UR, Nastasijević BTA, Joksić G, Dixit M (2013) Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts. PLoS ONE 8(4):e61393
Kondo Y, Takano F, Hojo H (1994) Suppression of chemically and immunologically induced hepatic injuries by gentiopicroside in mice. Planta Med 60(5):414–416
Kumarasamy Y, Nahar L, Sarker SD (2003) Bioactivity of gentiopicroside from the aerial parts of Centaurium erythraea. Fitoterapia 74(1–2):151–154
Li X, Yang C, Shen H (2019) Gentiopicroside exerts convincing antitumor effects in human ovarian carcinoma cells (SKOV3) by inducing cell cycle arrest, mitochondrial mediated apoptosis and inhibition of cell migration. J BUON 24(1):280–284
Lian LH, Wu YL, Wan Y, Li X, Xie WX, Nan JX (2010) Anti-apoptotic activity of gentiopicroside in D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. Chem Biol Interact 188(1):127–133
Liu SB, Zhao R, Li XS, Guo HJ, Tian Z, Zhang N, Gao GD, Zhao MG (2014) Attenuation of reserpine-induced pain/depression dyad by gentiopicroside through downregulation of GluN2B receptors in the amygdala of mice. NeuroMol Med 16(2):350–359
Liu N, Li YX, Gong SS, Du J, Liu G, Jin SJ, Zhao CJ, Niu Y, Sun T, Yu JQ (2016) Antinociceptive effects of gentiopicroside on neuropathic pain induced by chronic constriction injury in mice: a behavioral and electrophysiological study. Can J Physiol Pharmacol 94(7):769–778
Liu Q, Cheng L, Matsuura A, Xiang L, Qi J (2020) Gentiopicroside, a secoiridoid glycoside from Gentiana rigescens Franch, extends the lifespan of yeast via inducing mitophagy and antioxidative stress. Oxid Med Cell Longev 2020:9125752
Lu CM, Lin LC, Tsai TH (2014) Determination and pharmacokinetic study of gentiopicroside, geniposide, baicalin, and swertiamarin in Chinese herbal formulae after oral administration in rats by LC-MS/MS. Molecules (basel, Switzerland) 19(12):21560–21578
Lu Y, Yao J, Gong C, Wang B, Zhou P, Zhou S, Yao X (2018) Gentiopicroside ameliorates diabetic peripheral neuropathy by modulating PPAR- Γ/AMPK/ACC signaling pathway. Cell Physiol Biochem 50(2):585–596
Lv J, Gu WL, Chen CX (2015) Effect of gentiopicroside on experimental acute pancreatitis induced by retrograde injection of sodium taurocholate into the biliopancreatic duct in rats. Fitoterapia 102:127–133
Mihailović V, Mihailović M, Uskoković A, Arambašić J, Mišić D, Stanković V, Katanić J, Mladenović M, Solujić S, Matić S (2013) Hepatoprotective effects of Gentiana asclepiadea L. extracts against carbon tetrachloride induced liver injury in rats. Food Chem Toxicol 52:83–90
Mustafayeva K, Di Giorgio C, Elias R, Kerimov Y, Ollivier E, De Méo M (2010) DNA-damaging, mutagenic, and clastogenic activities of gentiopicroside isolated from Cephalaria kotschyi roots. J Nat Prod 73(2):99–103
Ni L, Zhao Z, Xu H, Chen S, Dorje G (2017) Chloroplast genome structures in Gentiana (Gentianaceae), based on three medicinal alpine plants used in Tibetan herbal medicine. Curr Genet 63(2):241–252
Niu YT, Zhao YP, Jiao YF, Zheng J, Yang WL, Zhou R, Niu Y, Sun T, Li YX, Yu JQ (2016) Protective effect of gentiopicroside against dextran sodium sulfate induced colitis in mice. Int Immunopharmacol 39:16–22
Oztürk N, Herekman-Demir T, Oztürk Y, Bozan B, Başer KH (1998) Choleretic activity of Gentiana lutea ssp. symphyandra in rats. Phytomedicine 5(4):283–288
Oztürk N, Başer KH, Aydin S, Oztürk Y, Caliş I (2002) Effects of Gentiana lutea ssp. symphyandra on the central nervous system in mice. Phytotherapy research: PTR 16(7):627–631
Pan Y, Zhao YL, Zhang J, Li WY, Wang YZ (2016) Phytochemistry and pharmacological activities of the genus Gentiana (Gentianaceae). Chem Biodivers 13(2):107–150
Pasdaran A, Butovska D, Kerr P, Naychov Z, Aneva I, Kozuharova E (2022) Gentians, natural remedies for the future of visceral pain control; an ethnopharmacological review with an in silico approach. Biol Futur 73(2):219–227. https://doi.org/10.1007/s42977-022-00114-7
Rojas A, Bah M, Rojas JI, Gutiérrez DM (2000) Smooth muscle relaxing activity of gentiopicroside isolated from Gentiana spathacea. Planta Med 66(8):765–767
Ruan M, Yu B, Xu L, Zhang L, Long J, Shen X (2015) Attenuation of stress-induced gastrointestinal motility disorder by gentiopicroside, from Gentiana macrophylla Pall. Fitoterapia 103:265–276
Savikin K, Menković N, Zdunić G, Stević T, Radanović D, Jankovićn T (2009) Antimicrobial activity of Gentiana lutea L. extracts Zeitschrift fur Naturforschung C. J Biosci 64(5–6):339–342
Sheng N, Zhi X, Yuan L, Zhang Z, Jia P, Zhang X, Zhang L, Wang X (2014) Pharmacokinetic and excretion study of three secoiridoid glycosides and three flavonoid glycosides in rat by LC-MS/MS after oral administration of the Swertia pseudochinensis extract. J Chromatogr B, Anal Technol Biomed Life Sci 967:75–83
Shi M, Xiong K, Zhang T, Han H (2020) Pharmacokinetics and metabolic profiles of swertiamarin in rats by liquid chromatography combined with electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 179:112997
Skinder BM, Ganai BA, Wani AH (2017) Scientific study of Gentiana kurroo Royle. Medicines (basel, Switzerland) 4(4):74
Sousa AMM, Meyer KA, Santpere G, Gulden FO, Sestan N (2017) Evolution of the human nervous system function, structure, and development. Cell 170(2):226–247
Sun JZ, Lv X, Xu SZ, Cai Q (2022) Determination and tissue distribution comparisons of gentiopicroside after oral administration of raw and wine-Processed Gentiana Radix. Pak J Pharm Sci 35(2):473–477
Talukdar S, Emdad L, Das SK, Sarkar D, Fisher PB (2016) Evolving strategies for therapeutically targeting cancer stem cells. Adv Cancer Res 131:159–191
Tang X, Yang Q, Yang F, Gong J, Han H, Yang L, Wang Z (2016) Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice. J Ethnopharmacol 194:63–71
Tong Y, Shi W, Zhang Q, Wang J (2023) Preparation, characterization, and in vivo evaluation of gentiopicroside-phospholipid complex (GTP-PC) and its self-nanoemulsion drug delivery system (GTP-PC-SNEDDS). Pharmaceuticals (basel, Switzerland) 16(1):99
Van der Sluis WG, van der Nat JM, Spek AL, Ikeshiro Y, Labadie RP (1983) Gentiogenal, a conversion product of gentiopicrin (gentiopicroside)*. Planta Med 49(12):211–215
Wan Z, Li H, Wu X, Zhao H, Wang R, Li M, Liu J, Liu Q, Wang R, Li X (2021) Hepatoprotective effect of gentiopicroside in combination with leflunomide and/or methotrexate in arthritic rats. Life Sci 265:118689
Wang CH, Wang ZT, Bligh SW, White KN, White CJ (2004) Pharmacokinetics and tissue distribution of gentiopicroside following oral and intravenous administration in mice. Eur J Drug Metab Pharmacokinet 29(3):199–203
Wang CH, Cheng XM, Bligh SW, White KN, Branford-White CJ, Wang ZT (2007) Pharmacokinetics and bioavailability of gentiopicroside from decoctions of Gentianae and Longdan Xiegan Tang after oral administration in rats–comparison with gentiopicroside alone. J Pharm Biomed Anal 44(5):1113–1117
Wang Q, Zhou X, Yang L, Luo M, Han L, Lu Y, Shi Q, Wang Y, Liang Q (2019) Gentiopicroside (GENT) protects against sepsis induced by lipopolysaccharide (LPS) through the NF-κB signaling pathway. Ann Transl Med 7(23):731
Wang M, Li H, Wang Y, Hao Y, Huang Y, Wang X, Lu Y, Du Y, Fu F, Xin W, Zhang L (2020) Anti-rheumatic properties of Gentiopicroside are associated with suppression of ROS-NF-κB-NLRP3 axis in fibroblast-like synoviocytes and NF-κB pathway in adjuvant-induced arthritis. Front Pharmacol 11:515
Wani BA, Ramamoorthy D, Rather MA, Arumugam N, Qazi AK, Majeed R, Hamid A, Ganie SA, Ganai BA, Anand R, Gupta AP (2013) Induction of apoptosis in human pancreatic MiaPaCa-2 cells through the loss of mitochondrial membrane potential (ΔΨm) by Gentiana kurroo root extract and LC-ESI-MS analysis of its principal constituents. Phytomedicine 20(8–9):723–733
Webb RC (2003) Smooth muscle contraction and relaxation. Adv Physiol Educ 27(1–4):201–206
Wu S, Yang L, Sun W, Si L, Xiao S, Wang Q, Dechoux L, Thorimbert S, Sollogoub M, Zhou D, Zhang Y (2017) Design, synthesis and biological evaluation of gentiopicroside derivatives as potential antiviral inhibitors. Eur J Med Chem 130:308–319
Xiao H, Sun X, Liu R, Chen Z, Lin Z, Yang Y, Zhang M, Liu P, Quan S, Huang H (2020) Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy. Pharmacol Res 151:104559
Xiao H, Sun X, Lin Z, Yang Y, Zhang M, Xu Z, Liu P, Liu Z, Huang H (2022) Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism. Acta Pharmaceutica Sinica B 12(6):2887–2904
Xie X, Li H, Wang Y, Wan Z, Luo S, Zhao Z, Liu J, Wu X, Li X, Li X (2019) Therapeutic effects of gentiopicroside on adjuvant-induced arthritis by inhibiting inflammation and oxidative stress in rats. Int Immunopharmacol 76:105840
Xing S, Nong F, Qin J, Huang H, Zhan R, Chen W (2021) Gentiopicroside produces endothelium-independent vasodilation by deactivating the PI3K/Akt/Rho-kinase pathway in isolated rat thoracic aorta. Biomed Res Int 2021:5565748
Xiong K, Gao T, Zhang T, Wang Z, Han H (2017) Simultaneous determination of gentiopicroside and its two active metabolites in rat plasma by LC-MS/MS and its application in pharmacokinetic studies. J Chromatogr B, Anal Technol Biomed Life Sci 1065–1066:1–7
Xu Z, Zhang M, Wang Y, Chen R, Xu S, Sun X, Yang Y, Lin Z, Wang S, Huang H (2022) Gentiopicroside ameliorates diabetic renal tubulointerstitial fibrosis via inhibiting the AT1R/CK2/NF-κB pathway. Front Pharmacol 13:848915
Yamada H, Kikuchi S, Inui T, Takahashi H, Kimura K (2014) Gentiolactone, a secoiridoid dilactone from Gentiana triflora, inhibits TNF-α, iNOS and Cox-2 mRNA expression and blocks NF-κB promoter activity in murine macrophages. PLoS ONE 9(11):e113834
Yang HX, Shang Y, Jin Q, Wu YL, Liu J, Qiao CY, Zhan ZY, Ye H, Nan JX, Lian LH (2020) Gentiopicroside ameliorates the progression from hepatic steatosis to fibrosis induced by chronic alcohol intake. Biomol Ther 28(4):320–327
Yao T, Cui Q, Liu Z, Wang C, Zhang Q, Wang G (2019) Metabolomic evidence for the therapeutic effect of gentiopicroside in a corticosterone-induced model of depression. Biomed Pharmacother = Biomedecine Pharmacotherapie 120:109549
Yin W, Wang J, Jiang L, James Kang Y (2021) Cancer and stem cells. Exp Biol Med (Maywood, N.J.) 246(16):1791–1801
Zeng R, Hu H, Ren G, Liu H, Qu Y, Hua W, Wang Z (2015) Chemical profiling assisted quality assessment of Gentianae macrophyllae by high-performance liquid chromatography using a fused-core column. J Chromatogr Sci 53(8):1274–1279
Zhang X, Zhan G, Jin M, Zhang H, Dang J, Zhang Y, Guo Z, Ito Y (2018) Botany, traditional use, phytochemistry, pharmacology, quality control, and authentication of Radix Gentianae Macrophyllae-A traditional medicine: a review. Phytomedicine 46:142–163
Zhang N, Jiang Y, Mu F, Wu H, You Q (2019) Gentiopicrin exerts anti-rheumatic effect in human fibroblast-like synoviocytes via inhibition of p38MAPK/NF-κB pathway. Cell Mol Biol (Noisy-le-Grand, France) 65(6):85–90
Zhang Y, Yang X, Wang S, Song S, Yang X (2021) Gentiopicroside prevents alcoholic liver damage by improving mitochondrial dysfunction in the rat model. Phytother Res: PTR 35(4):2230–2251
Zhang QL, Xia PF, Peng XJ, Wu XY, Jin H, Zhang J, Zhao L (2022) Synthesis, and anti-inflammatory activities of gentiopicroside derivatives. Chin J Nat Med 20(4):309–320
Zhao L, Ye J, Wu GT, Peng XJ, Xia PF, Ren Y (2015) Gentiopicroside prevents interleukin-1 beta induced inflammation response in rat articular chondrocyte. J Ethnopharmacol 172:100–107
Zhou W, Ouyang J, Wang H, Wang X (2019) Antidermatophyte activity of the gentiopicroside-rich n-butanol fraction from Gentiana siphonantha maxim. Root on a guinea pig model of dermatophytosis. Complement Med Res 26(1):31–38
Zou B, Fu Y, Cao C, Pan D, Wang W, Kong L (2021) Gentiopicroside ameliorates ovalbumin-induced airway inflammation in a mouse model of allergic asthma via regulating SIRT1/NF-κB signaling pathway. Pulm Pharmacol Ther 68:102034
Zou XZ, Zhang YW, Pan ZF, Hu XP, Xu YN, Huang ZJ, Sun ZY, Yuan MN, Shi JN, Huang P, Liu T (2022) Gentiopicroside alleviates cardiac inflammation and fibrosis in T2DM rats through targeting Smad3 phosphorylation. Phytomedicine 106:154389
Funding
This study was funded by National Natural Science Foundation of China (81873163) and the Key Project of Natural Science Foundation of Shandong Province (ZR2020KC024).
Author information
Authors and Affiliations
Contributions
Bin Liu and Feng Pang: writing—original draft, visualization; Hongsheng Bi and Dadong Guo: conceptualization, resources, writing—review and editing, funding acquisition.
The authors confirm that no paper mill and artificial intelligence was used.
Corresponding author
Ethics declarations
Ethical approval
None of the authors of this article conducted any studies involving human participants or animals.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Highlights
1. GPS can treat arthralgia, stroke, hemiplegia, pains, jaundice, and infantile malnutrition.
2. GPS exhibits hepatoprotective, antifibrosis, antioxidant, and antitumor effects.
3. GPS can play a role in anti-inflammatory and immunomodulatory activities.
4. Regulatory mechanisms of GPS on multiple human diseases were illustrated.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, B., Pang, F., Bi, H. et al. Regulatory mechanisms of Gentiopicroside on human diseases: a brief review. Naunyn-Schmiedeberg's Arch Pharmacol 397, 725–750 (2024). https://doi.org/10.1007/s00210-023-02672-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-023-02672-6